Baltimore, MD
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.
delfidiagnostics.comThese are collections Delfi Diagnostics is a part of. Click on the collection name to view similar companies.
Series B
$225,000,000
Series A
$100,000,000
Seed
$5,500,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Delfi Diagnostics.